Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals M.E. Reverdy, S. Jarraud, S. Bohin-Duhreux, E.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.

G. Cornaglia, A. Lönnroth, M. Struelens

M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Herpes zoster in non-hospitalized children

Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum Ronald N. Jones, M.D., Mary.

In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus A. Carricajo,

E. Lindberg, I. Adlerberth, A.E. Wold

Clinical impact of antibiotic-resistant Gram-positive pathogens

Cost-effectiveness of universal MRSA screening on admission to surgery

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality K. Bouiller, H. Gbaguidi-Haore,

N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98 J. Robert, E. Cambau, K. Grenet, D.

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on.

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

P. Moreillon, J.M. Entenza Clinical Microbiology and Infection

Do we need new antibiotics?

Spa typing directly from a mecA, spa and pvl multiplex PCR assay—a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance

Training for the infectious diseases speciality in Norway

A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V K. Boye, M.D. Bartels, I.S. Andersen, J.A. Møller,

Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci.

Development of antimicrobial resistance in Staphylococcus lugdunensis during treatment—report of a case of bacterial arthritis, vertebral osteomyelitis.

E.C. Böttger Clinical Microbiology and Infection

Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries A. Deplano, W. Witte, W.J. Van Leeuwen,

The use and therapeutic drug monitoring of teicoplanin in the UK

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Bacterial resistance—the clinical challenge

PCR for the identification of methicillin-resistant Staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the.

C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R

False synergy between vancomycin and β-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis R. Diaz, V. Afreixo,

Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.

Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France M. Thouverez,

M. Aires-de-Sousa Clinical Microbiology and Infection

MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.

Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals E.E. Udo, N. Al-Sweih, B.

Laboratory diagnosis of Clostridium difficile disease

N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti

Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.

Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen

Can β-lactams be re-engineered to beat MRSA?

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals G.L. Cartolano,

A.W. Karchmer Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year.

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

Epidemiological relatedness of methicillin-resistant Staphylococcus aureus from a tertiary hospital and a geriatric institution in Spain E. Ruiz de Gopegui,

Effect of antibiotics, alone and in combination, on Panton–Valentine leukocidin production by a Staphylococcus aureus reference strain O. Dumitrescu,

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

Can pharmacokinetic–pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance? P. Courvalin Clinical Microbiology and.

Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France D.

E. Tacconelli Clinical Microbiology and Infection

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection M. Croze, O. Dauwalder, O. Dumitrescu,

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

G.C. Schito Clinical Microbiology and Infection

Typing of Clostridium difficile

AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on.

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant.

The first glycopeptide-intermediate Staphylococcus aureus in Oman

Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods C. Muller-Serieys,

Presentation transcript:

Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals M.E. Reverdy, S. Jarraud, S. Bohin-Duhreux, E. Buret, P. Girardo, G. Lina, F. Vandenesch, J. Etienne Clinical Microbiology and Infection Volume 7, Issue 5, Pages 267-272 (May 2001) DOI: 10.1046/j.1198-743x.2001.00256.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Vancomycin and teicoplanin MICs for 81 S. aureus isolates, determined by the agar dilution (▪) or E test method (□). Clinical Microbiology and Infection 2001 7, 267-272DOI: (10.1046/j.1198-743x.2001.00256.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Population analysis of S. aureus strains PAD, GUE and MER and of control strain ATCC 29213. Bacteria grown overnight were serially diluted and plated on various concentrations of vancomycin-containing agar medium. Clinical Microbiology and Infection 2001 7, 267-272DOI: (10.1046/j.1198-743x.2001.00256.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Schematic representation of the pulsotypes of methicillin-resistant GISA or hGISA isolates (PAD245, PAD346, PAD438, GUE, LIM-2, and Mu50) with their respective origin from France or Japan, methicillin-resistant hGISA isolate (Mu3), methicillin-susceptible hGISA isolate (MER) and control isolates (ATCC 25923 and ATCC 29213). S. aureus NCTC 8325 was used as a size marker. Fragment sizes in the upper margin are in kb. Clinical Microbiology and Infection 2001 7, 267-272DOI: (10.1046/j.1198-743x.2001.00256.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 Composite picture showing the morphology of vancomycin-susceptible S. aureus strain ATCC 29213 (A), and morphologic abnormalities of GISA strain PAD (B) and hGISA strains GUE (C) and MER (D). Magnification × 40 000. Clinical Microbiology and Infection 2001 7, 267-272DOI: (10.1046/j.1198-743x.2001.00256.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions